Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Cohen-Wolkowiez, MD, PhD
Duke Clinical Research Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
58 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Pleven, Bulgaria
- Facility name not stated
Plovdiv, Bulgaria
- Facility name not stated
Rousse, Bulgaria
- Facility name not stated
Sofia, Bulgaria
- Facility name not stated
Sofia, Bulgaria
- Facility name not stated
Sofia, Bulgaria
- Facility name not stated
Vratsa, Bulgaria
- Facility name not stated
Budapest, Hungary
- Facility name not stated
Budapest, Hungary
- Facility name not stated
Budapest, Hungary
- Facility name not stated
Budapest, Hungary
- Facility name not stated
Cegléd, Hungary
- Facility name not stated
Debrecen, Hungary
- Facility name not stated
Gyula, Hungary
- Facility name not stated
Győr, Hungary
- Facility name not stated
Mosdós, Hungary
- Facility name not stated
Nagykanizsa, Hungary
- Facility name not stated
Nyíregyháza, Hungary
- Facility name not stated
Szeged, Hungary
- Facility name not stated
Székesfehérvár, Hungary
- Facility name not stated
Törökbálint, Hungary
- Facility name not stated
Veszprém, Hungary
- Facility name not stated
Caloocan, Philippines
- Facility name not stated
Cebu City, Philippines
- Facility name not stated
City of Muntinlupa, Philippines
- Facility name not stated
Davao City, Philippines
- Facility name not stated
Iloilo City, Philippines
- Facility name not stated
Manila, Philippines
- Facility name not stated
Quezon City, Philippines
- Facility name not stated
Quezon City, Philippines
- Facility name not stated
Esplugues de Llobregat, Barcelona, Spain
- Facility name not stated
Donostia / San Sebastian, Guipuzcoa, Spain
- Facility name not stated
Barcelona, Spain
- Facility name not stated
Barcelona, Spain
- Facility name not stated
Madrid, Spain
- Facility name not stated
London, United Kingdom
- Facility name not stated
London, United Kingdom
- Facility name not stated
Little Rock, Arkansas, United States
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
Sacramento, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2016
- Primary completion
- 21 Mar 2018
- Completion
- 21 Mar 2018
- Last update posted
- 3 Jan 2019
- Registered enrollment
- 97
- Registry id
- NCT02605122
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.